This decommissioned ERA site remains active temporarily to support our final migration steps to https://ualberta.scholaris.ca, ERA's new home. All new collections and items, including Spring 2025 theses, are at that site. For assistance, please contact erahelp@ualberta.ca.
Search
Skip to Search Results- 2Al Sayah, Fatima
- 1Adame Perez, Stephany
- 1Al-Adra, David P.
- 1Albalawi, Zaina H
- 1Anderson, Sarah J
- 1Asaad, Ghada A
- 8Department of Agricultural, Food, and Nutritional Science
- 6Department of Surgery
- 4School of Public Health
- 3Department of Medicine
- 3Faculty of Pharmacy and Pharmaceutical Sciences
- 2Department of Medical Microbiology and Immunology
- 2Johnson, Jeff A. (School of Public Health Sciences, University of Alberta)
- 2Williams, Beverly (Faculty of Nursing, University of Alberta)
- 1Al Hamarneh, Yazid (Pharmacology)
- 1Anderson, Colin (Medical Microbiology and Immunology and Surgery)
- 1Baldwin, Troy (Medical Microbiology and Immunology)
- 1Chan, Catherine (Agricultural, Food and Nutritional Sciences)
-
Clinical and Translational Studies Advancing Clinical Implementation of Stem Cell-Derived Islet Transplantation
DownloadSpring 2024
Twenty-years ago Shapiro et al. revolutionized islet transplantation (ITx), realizing the potential for a cell-based diabetes treatment. Despite improvements, ITx remains restricted by organ donor limitations and immunosuppression. Stem cell (SC)-derived ITx (SC Tx) could eliminate these...
-
Heart Failure Related Outcomes in Patients within a Specialized Clinic-Based Cohort and a Population Level Cohort: Emphasis on Diabetes
DownloadFall 2024
Diabetes mellitus (DM) is a well-established risk factor for adverse prognosis in patients with heart failure (HF). Outcomes in this patient population have not been thoroughly investigated in specialized heart function clinics (HFC). Recently, sodium-glucose cotransporter-2 (SGLT2) inhibitors...
-
Fall 2024
Obesity is a major public health problem since it is associated with different complications, including cardiovascular diseases, cancer, type 2 diabetes (T2D), and a higher risk of infections. This is due in part to the fact that obesity is characterized by the presence of chronic low-grade...
-
Fall 2024
Background: Dyslipidemia is a common characteristic in both diabetes and obesity, due in part to elevated triglyceride (TG)-rich very-low density lipoprotein (VLDL-TG) secretion from the liver. Excessive levels and/or action of glucocorticoids (GCs) is also observed in these metabolic diseases...
-
Non-fasting remnant cholesterol as a predictor for cardiovascular disease risk in Canadians with and without diabetes mellitus in the Alberta’s Tomorrow Project
DownloadFall 2022
Cardiovascular disease (CVD) is a leading cause of death in Canada, and its risk of development is 3 times greater in those with diabetes mellitus (DM). Fasting low-density lipoprotein cholesterol (LDL-C) is the traditional lipid biomarker used in CVD risk assessment. While lowering LDL-C does...
-
Spring 2021
As one of the most accessible primary health care providers, pharmacists are in an excellent position to provide primary health care services. Although slow, the current transition from a dispensing-centered (transaction-based) pharmacy approach to a patient-centered (patient care based) approach...
-
Cause of Death and the Impact of Implantable Cardioverter Defibrillators Among Patients with Diabetes Mellitus and Heart Failure
DownloadSpring 2020
Introduction: Diabetes and heart failure (HF) place a large burden on healthcare systems and are associated with increased risk for death, including sudden cardiac death (SCD). However, causes of death have not been fully explored and evidence for primary prevention...
-
Exploring the Relationship Between Depression and Adherence in Individuals with Type 2 Diabetes
DownloadFall 2020
Background: Depression is a well-known risk factor for poor medication adherence in individuals with diabetes; however, this association is based on cross-sectional and cohort studies measuring adherence after depression is diagnosed. Symptoms of depression often progress before medical...
-
Fall 2020
2-aminoadipic acid (2-AAA) has been identified as an accurate long-term biomarker for the future development of diabetes. An investigation of over 2000 patients found that patients in the upper quartile of initial blood 2-AAA levels showed a 2-4x higher incidence of diabetes development over the...
-
Vitamin D Status and Health-care Outcomes in an Ambulatory Population of Patients with Diabetes and Chronic Kidney disease: A Five-year Follow-up.
DownloadSpring 2018
Vitamin D (VitD) deficiency is a prevalent condition in Canada, especially in northern latitudes where sunlight exposure is limited. Elderly patients especially those with chronic conditions such as Diabetes Mellitus (DM) and Chronic Kidney Disease (CKD) have a higher risk of developing vitD...